Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Equity Average (2016 - 2026)

Avanos Medical's Equity Average history spans 13 years, with the latest figure at $778.1 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 24.39% to $778.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $778.1 million, a 24.39% decrease, with the full-year FY2025 number at $803.3 million, down 22.19% from a year prior.
  • Equity Average hit $778.1 million in Q4 2025 for Avanos Medical, up from $400000.0 in the prior quarter.
  • Over the last five years, Equity Average for AVNS hit a ceiling of $1.5 billion in Q1 2023 and a floor of -$738.8 million in Q2 2025.
  • Historically, Equity Average has averaged $851.8 million across 5 years, with a median of $920.2 million in 2023.
  • Biggest five-year swings in Equity Average: soared 4661.68% in 2021 and later crashed 193.73% in 2025.
  • Tracing AVNS's Equity Average over 5 years: stood at $1.3 billion in 2021, then grew by 0.67% to $1.3 billion in 2022, then fell by 3.77% to $1.2 billion in 2023, then decreased by 16.28% to $1.0 billion in 2024, then fell by 24.39% to $778.1 million in 2025.
  • Business Quant data shows Equity Average for AVNS at $778.1 million in Q4 2025, $400000.0 in Q3 2025, and -$738.8 million in Q2 2025.